Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-sensitive potassium channels (KATP channels) are a class of potassium ion channels that couple the metabolic state of a cell to its electrical activity. They are hetero-octameric complexes composed of four pore-forming Kir6.x subunits (Kir6.1 or Kir6.2) and four regulatory sulfonylurea receptor (SURx) subunits (SUR1, SUR2A, or SUR2B). The channel's activity is regulated by intracellular ATP and ADP levels, with high ATP/ADP ratios closing the channel and low ratios opening it. KATP channels play crucial roles in various tissues, including pancreatic beta cells (insulin secretion), cardiac myocytes (protection during ischemia), and vascular smooth muscle (regulation of vascular tone). Mutations in genes encoding KATP channel subunits can cause diseases such as congenital hyperinsulinism or neonatal diabetes.
Modulation of channel opening probability in response to intracellular ATP/ADP ratio. Sulfonylureas inhibit the channel by binding to the SUR subunit. Diazoxide and related compounds increase channel opening probability.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium Channel (ATP-sensitive) (KATP).